CCND1 and neoplasm: Targeting Smad followed by conventional therapy induces CSC differentiation resulting in significant chemosensitization in cyclin D1-spheres and cyclin D1-sphere-derived xenograft tumor, highlighting the usage of small molecule (Smad inhibitor) to induce CSC differentiation and chemosensitization could be an effective strategy for targeting CSCs.